Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort
Recruiting
- Conditions
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 10000
- Registration Number
- NCT02839863
- Locations
- π³π±
Ziekenhuisgroep Twente, Almelo, Netherlands
π³π±Alrijne Ziekenhuis, Leiderdorp, Netherlands
π³π±St. Antonius Ziekenhuis, Nieuwegein, Netherlands
A Randomized, Placebo-controlled, Double Blind Trial to Investigate Whether Vitamin K2 Can Influence Arterial Calcification in Patients With Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 68
- Registration Number
- NCT02839044
- Locations
- π³π±
UMC Utrecht, Utrecht, Netherlands
Parameters of Cerebral Perfusion
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 15
- Registration Number
- NCT02806492
- Locations
- π³π±
UMC Utrecht, Utrecht, Netherlands
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3
Recruiting
- Conditions
- Interventions
- Other: No systemic corticosteroidOther: No antiviral agent for COVID-19Other: No immune modulation for COVID-19Drug: Standard course macrolideOther: No antiviral agent for influenzaDrug: Local standard venous thromboprophylaxisOther: No immunoglobulinOther: No simvastatinOther: No cysteamineOther: No Immune Modulator for InfluenzaOther: No vitamin COther: No antiplateletProcedure: Clinician-preferred mechanical ventilation strategyOther: No renin-angiotensin system inhibitorOther: No endothelial modulatorDrug: CeftriaxoneDrug: Moxifloxacin or LevofloxacinDrug: Extended course macrolideDrug: Fixed-duration HydrocortisoneDrug: Five-days oseltamivirDrug: Lopinavir / RitonavirBiological: Convalescent plasmaDrug: Angiotensin converting enzyme inhibitorDrug: Nirmatrelvir/ritonavirDrug: Therapeutic dose anticoagulationProcedure: Protocolised mechanical ventilation strategyDrug: Interferon beta-1aDrug: Vitamin CDrug: SimvastatinDrug: AspirinDrug: EritoranDrug: CysteamineDrug: ImatinibDrug: Shock-dependent hydrocortisoneDrug: Ten-days oseltamivirDrug: P2Y12 inhibitorDrug: Angiotensin Receptor BlockersDrug: Conventional low dose thromboprophylaxisBiological: Delayed administration of convalescent plasmaDrug: Piperacillin-tazobactamDrug: HydroxychloroquineDrug: AnakinraDrug: ApremilastDrug: BaricitinibDrug: RemdesivirDrug: Fixed-duration higher dose HydrocortisoneDrug: Hydroxychloroquine + lopinavir/ritonavirDrug: Intermediate dose thromboprophylaxisDrug: Nirmatrelvir/ritonavir + remdesivirDrug: ARB + DMX-200Drug: CeftarolineDrug: Baloxavir MarboxilDrug: TocilizumabDrug: Amoxicillin-clavulanateDrug: Fixed-duration dexamethasoneDrug: Five-days oseltamivir + baloxavir marboxilDrug: Continuation of therapeutic dose anticoagulationDrug: IvermectinDrug: SarilumabDrug: Ten-days oseltamivir + baloxavir marboxil
- First Posted Date
- 2016-04-13
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 20000
- Registration Number
- NCT02735707
- Locations
- π¨π¦
Toronto Western Hospital, Toronto, Ontario, Canada
πΊπΈUniversity of Illinois Health, Chicago, Illinois, United States
π¦πΊBankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia
Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2018-10-18
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 195
- Registration Number
- NCT02725203
- Locations
- π³π±
GP Odijk-Visser, Heerhugowaard, Noord-Holland, Netherlands
π³π±GP Lienderweg, Asten, Brabant, Netherlands
π³π±GP Tjin a Ton and Parlevliet, Amstelveen, Noord-Holland, Netherlands
Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy
- First Posted Date
- 2016-02-18
- Last Posted Date
- 2019-10-14
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 5
- Registration Number
- NCT02685046
- Locations
- π³π±
Diakonessenhuis, Utrecht, Netherlands
π³π±Meander Medical Center, Amersfoort, Utrecht, Netherlands
π³π±University Medical Center Utrecht, Utrecht, Netherlands
Direct Evaluation of Postoperative Myocardial Injury Using Coronary Computed Tomography Angiography After Non-Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2016-02-17
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 354
- Registration Number
- NCT02682966
EMR Versus ESD for Resection of Large Distal Non-pedunculated Colorectal Adenomas
- First Posted Date
- 2016-01-15
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 212
- Registration Number
- NCT02657044
- Locations
- π³π±
UMC Utrecht, Utrecht, Netherlands
Targeted Vessel Ablation of Type 3 Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 6
- Registration Number
- NCT02633254
- Locations
- π³π±
University Medical Center Utrecht, Utrecht, Netherlands
Shock Wave Therapy for Osteoporosis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-12-15
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 12
- Registration Number
- NCT02630381
Β© Copyright 2024. All Rights Reserved by MedPath